TheraRadar
← Back
Data updated: Mar 29, 2026

WILSHIRE PHARMS INC

ImmunologyRespiratoryGastroenterology
Generics

WILSHIRE PHARMS INC is a generic drug manufacturer focused on Immunology, Respiratory, Gastroenterology.

2015
Since
11
Drugs
-
Trials
73
Approved (2yr)

Key Drugs

MERZEE
ethinyl estradiol
· 2020

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

DEXMEDETOMIDINE HYDROCHLORIDE 2026-02-17
Labeling
METHYLPREDNISOLONE ACETATE 2026-01-26
METHYLPREDNISOLONE ACETATE 2026-01-20
Labeling
METHYLPREDNISOLONE ACETATE 2026-01-20
Labeling
TESTOSTERONE CYPIONATE 2025-07-21
Labeling
TESTOSTERONE CYPIONATE 2025-07-21
Labeling
TESTOSTERONE CYPIONATE 2025-07-14
Labeling
TESTOSTERONE CYPIONATE 2025-07-11
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Immunology 32%
0 drugs Phase 3: 7
Respiratory 22%
3 drugs Phase 1: 1
Gastroenterology 18%
0 drugs Phase 3: 4
Metabolic 14%
0 drugs Phase 3: 2 Phase 1: 4
Infectious Disease 14%
0 drugs Phase 3: 3

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Sanofi big-pharma
Metabolic, Infectious Disease, Immunology, Respiratory
Pfizer big-pharma
Infectious Disease, Immunology, Gastroenterology
Merck big-pharma
Infectious Disease, Immunology, Metabolic
PHARMACIA AND UPJOHN big-pharma
Infectious Disease, Respiratory, Immunology, Metabolic
Gilead Sciences biotech
Infectious Disease, Immunology, Gastroenterology, Respiratory